Cargando…

Pandemic influenza: overview of vaccines and antiviral drugs.

Pandemic influenza has become a high priority item for all public health authorities. An influenza pandemic is believed to be imminent, and scientists agree that it will be a matter of when, where, and what will be the causative agent. Recently, most attention has been directed to human cases of avi...

Descripción completa

Detalles Bibliográficos
Autor principal: Cox, Manon M. J.
Formato: Texto
Lenguaje:English
Publicado: Yale Journal of Biology and Medicine 2005
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2259155/
https://www.ncbi.nlm.nih.gov/pubmed/17132338
_version_ 1782151353855901696
author Cox, Manon M. J.
author_facet Cox, Manon M. J.
author_sort Cox, Manon M. J.
collection PubMed
description Pandemic influenza has become a high priority item for all public health authorities. An influenza pandemic is believed to be imminent, and scientists agree that it will be a matter of when, where, and what will be the causative agent. Recently, most attention has been directed to human cases of avian influenza caused by a H5N1 avian influenza virus. An effective vaccine will be needed to substantially reduce the impact of an influenza pandemic. Current influenza vaccine manufacturing technology is not adequate to support vaccine production in the event of an avian influenza outbreak, and it has now become clear that new innovative production technology is required. Antiviral drugs, on the other hand, can play a very important role in slowing the disease spread but are in short supply and resistance has been a major issue. Here, we provide an update on the status of pandemic vaccine development and antiviral drugs. Finally, we conclude with some proposed areas of focus in pandemic vaccine preparedness.
format Text
id pubmed-2259155
institution National Center for Biotechnology Information
language English
publishDate 2005
publisher Yale Journal of Biology and Medicine
record_format MEDLINE/PubMed
spelling pubmed-22591552008-03-03 Pandemic influenza: overview of vaccines and antiviral drugs. Cox, Manon M. J. Yale J Biol Med Research Article Pandemic influenza has become a high priority item for all public health authorities. An influenza pandemic is believed to be imminent, and scientists agree that it will be a matter of when, where, and what will be the causative agent. Recently, most attention has been directed to human cases of avian influenza caused by a H5N1 avian influenza virus. An effective vaccine will be needed to substantially reduce the impact of an influenza pandemic. Current influenza vaccine manufacturing technology is not adequate to support vaccine production in the event of an avian influenza outbreak, and it has now become clear that new innovative production technology is required. Antiviral drugs, on the other hand, can play a very important role in slowing the disease spread but are in short supply and resistance has been a major issue. Here, we provide an update on the status of pandemic vaccine development and antiviral drugs. Finally, we conclude with some proposed areas of focus in pandemic vaccine preparedness. Yale Journal of Biology and Medicine 2005-10 /pmc/articles/PMC2259155/ /pubmed/17132338 Text en
spellingShingle Research Article
Cox, Manon M. J.
Pandemic influenza: overview of vaccines and antiviral drugs.
title Pandemic influenza: overview of vaccines and antiviral drugs.
title_full Pandemic influenza: overview of vaccines and antiviral drugs.
title_fullStr Pandemic influenza: overview of vaccines and antiviral drugs.
title_full_unstemmed Pandemic influenza: overview of vaccines and antiviral drugs.
title_short Pandemic influenza: overview of vaccines and antiviral drugs.
title_sort pandemic influenza: overview of vaccines and antiviral drugs.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2259155/
https://www.ncbi.nlm.nih.gov/pubmed/17132338
work_keys_str_mv AT coxmanonmj pandemicinfluenzaoverviewofvaccinesandantiviraldrugs